DyeVert™ PLUS

Taking Kidney Care to Heart

Revolutionary contrast reduction,
uncompromised imaging.

Have a Heart, Be Kind to Kidneys™

At Osprey Medical, our mission is to improve outcomes in patients with Chronic Kidney Disease by reducing contrast induced Acute Kidney Injury (AKI) and lowering hospital costs. Osprey’s proprietary technologies reduce the amount of contrast (dye) injected into patients during heart catheterization procedures without compromising X-ray image quality for the physician.

Learn more

We are Osprey Medical

Our vision is to make angiography safer for CKD patients.

Kidney Care – Reducing AKI in the Cath Lab

Kidney Care is about reducing AKI in the Cath Lab

Clinical Guidelines outline Kidney Care Protocols

Learn more

Uncompromised Dye Reduction

The only FDA indicated technology for reducing dye dosage to patients

Watch the video

DyeVert™ PLUS. Taking Kidney Care to Heart.

See the revolutionary technology indicated to reduce harmful contrast (dye) dosage delivered to patients.

Learn more

Watch the video

Cutting Down on Dye May Make Heart Procedures Safer for Kidney Patients

June 8, 2017

San Antonio's University Hospital is one of the first hospitals to use a device called DyeVert Plus. Bluetooth technology embedded in the syringe uses wireless transmission to track exactly how much dye is used for each image. Tests of the new device show it can reduce the amount of dye used in heart procedures on kidney patients by as much as 40 percent.

Osprey Medical Receives US FDA Clearance for DyeVert™ Plus

March 9, 2017

Osprey Medical today announced that it has received US FDA 510(k) clearance for its advanced DyeVert™ PLUS Contrast Reduction System. This new platform augments Osprey's current technology with the capability to actively manage dye administration during coronary interventions.

Photo credit (Kidney Care): Blausen.com staff (2014). “Medical gallery of Blausen Medical 2014“. WikiJournal of Medicine 1 (2). DOI:10.15347/wjm/2014.010. ISSN 2002-4436.